A new class of broadly neutralizing antibodies that target the glycan loop of Zika virus envelope protein

por Qu, Panke, Zhang, Chao, Li, Min, Ma, Weimin, Xiong, Pei, Liu, Qingwei, Zou, Gang, Lavillette, Dimitri, Yin, Feifei, Jin, Xia, Huang, Zhong
Publicado 2020

Determinants and Mechanisms of the Low Fusogenicity and Endosomal Entry of Omicron Subvariants

por Qu, Panke, Evans, John P., Kurhade, Chaitanya, Zeng, Cong, Zheng, Yi-Min, Xu, Kai, Shi, Pei-Yong, Xie, Xuping, Liu, Shan-Lu
Publicado 2022

Determinants and Mechanisms of the Low Fusogenicity and High Dependence on Endosomal Entry of Omicron Subvariants

por Qu, Panke, Evans, John P., Kurhade, Chaitanya, Zeng, Cong, Zheng, Yi-Min, Xu, Kai, Shi, Pei-Yong, Xie, Xuping, Liu, Shan-Lu
Publicado 2023

COVID-19 mRNA booster vaccines elicit strong protection against SARS-CoV-2 Omicron variant in patients with cancer

por Zeng, Cong, Evans, John P., Chakravarthy, Karthik, Qu, Panke, Reisinger, Sarah, Song, No-Joon, Rubinstein, Mark P., Shields, Peter G., Li, Zihai, Liu, Shan-Lu
Publicado 2022

Evasion of Neutralizing Antibody Response by the SARS-CoV-2 BA.2.75 Variant

por Qu, Panke, Evans, John P., Zheng, Yi-Min, Carlin, Claire, Saif, Linda J., Oltz, Eugene M., Xu, Kai, Gumina, Richard J., Liu, Shan-Lu
Publicado 2022

Evasion of neutralizing antibody responses by the SARS-CoV-2 BA.2.75 variant

por Qu, Panke, Evans, John P., Zheng, Yi-Min, Carlin, Claire, Saif, Linda J., Oltz, Eugene M., Xu, Kai, Gumina, Richard J., Liu, Shan-Lu
Publicado 2022

Neutralization of SARS-CoV-2 Variants of Concern Harboring Q677H

por Zeng, Cong, Evans, John P., Faraone, Julia N., Qu, Panke, Zheng, Yi-Min, Saif, Linda, Oltz, Eugene M., Lozanski, Gerard, Gumina, Richard J., Liu, Shan-Lu
Publicado 2021

Erratum for Zeng et al., “Neutralization of SARS-CoV-2 Variants of Concern Harboring Q677H”

por Zeng, Cong, Evans, John P., Faraone, Julia N., Qu, Panke, Zheng, Yi-Min, Saif, Linda, Oltz, Eugene M., Lozanski, Gerard, Gumina, Richard J., Liu, Shan-Lu
Publicado 2021

Durability of the Neutralizing Antibody Response to mRNA Booster Vaccination Against SARS-CoV-2 BA.2.12.1 and BA.4/5 Variants

por Qu, Panke, Faraone, Julia N., Evans, John P., Zheng, Yi-Min, Carlin, Claire, Lozanski, Gerard, Saif, Linda J., Oltz, Eugene M., Gumina, Richard J., Liu, Shan-Lu
Publicado 2022

Immune evasion and membrane fusion of SARS-CoV-2 XBB subvariants EG.5.1 and XBB.2.3

por Faraone, Julia N., Qu, Panke, Goodarzi, Negin, Zheng, Yi-Min, Carlin, Claire, Saif, Linda J., Oltz, Eugene M., Xu, Kai, Jones, Daniel, Gumina, Richard J., Liu, Shan-Lu
Publicado 2023

Durability of Booster mRNA Vaccine against SARS-CoV-2 BA.2.12.1, BA.4, and BA.5 Subvariants

por Qu, Panke, Faraone, Julia N., Evans, John P., Zheng, Yi-Min, Yu, Lianbo, Ma, Qin, Carlin, Claire, Lozanski, Gerard, Saif, Linda J., Oltz, Eugene M., Gumina, Richard J., Liu, Shan-Lu
Publicado 2022

Neutralizing antibody against SARS-CoV-2 spike in COVID-19 patients, health care workers, and convalescent plasma donors

por Zeng, Cong, Evans, John P., Pearson, Rebecca, Qu, Panke, Zheng, Yi-Min, Robinson, Richard T., Hall-Stoodley, Luanne, Yount, Jacob, Pannu, Sonal, Mallampalli, Rama K., Saif, Linda, Oltz, Eugene, Lozanski, Gerard, Liu, Shan-Lu
Publicado 2020

Neutralization of the SARS-CoV-2 Deltacron and BA.3 Variants

por Evans, John P., Qu, Panke, Zeng, Cong, Zheng, Yi-Min, Carlin, Claire, Bednash, Joseph S., Lozanski, Gerard, Mallampalli, Rama K., Saif, Linda J., Oltz, Eugene M., Mohler, Peter J., Gumina, Richard J., Liu, Shan-Lu
Publicado 2022

Immune Evasion, Infectivity, and Fusogenicity of SARS-CoV-2 Omicron BA.2.86 and FLip Variants

por Qu, Panke, Xu, Kai, Faraone, Julia N., Goodarzi, Negin, Zheng, Yi-Min, Carlin, Claire, Bednash, Joseph S., Horowitz, Jeffrey C., Mallampalli, Rama K., Saif, Linda J., Oltz, Eugene M., Jones, Daniel, Gumina, Richard J., Liu, Shan-Lu
Publicado 2023

Neutralization of the SARS-CoV-2 Omicron BA.4/5 and BA.2.12.1 Subvariants

por Qu, Panke, Faraone, Julia, Evans, John P., Zou, Xue, Zheng, Yi-Min, Carlin, Claire, Bednash, Joseph S., Lozanski, Gerard, Mallampalli, Rama K., Saif, Linda J., Oltz, Eugene M., Mohler, Peter J., Gumina, Richard J., Liu, Shan-Lu
Publicado 2022

Neutralization escape of Omicron XBB, BR.2, and BA.2.3.20 subvariants

por Faraone, Julia N., Qu, Panke, Evans, John P., Zheng, Yi-Min, Carlin, Claire, Anghelina, Mirela, Stevens, Patrick, Fernandez, Soledad, Jones, Daniel, Lozanski, Gerard, Panchal, Ashish, Saif, Linda J., Oltz, Eugene M., Gumina, Richard J., Liu, Shan-Lu
Publicado 2023

Extraordinary Evasion of Neutralizing Antibody Response by Omicron XBB.1.5, CH.1.1 and CA.3.1 Variants

por Qu, Panke, Faraone, Julia N., Evans, John P., Zheng, Yi-Min, Carlin, Claire, Anghelina, Mirela, Stevens, Patrick, Fernandez, Soledad, Jones, Daniel, Panchal, Ashish, Saif, Linda J., Oltz, Eugene M., Xu, Kai, Gumina, Richard J., Liu, Shan-Lu
Publicado 2023

Neutralization and Stability of SARS-CoV-2 Omicron Variant

por Zeng, Cong, Evans, John P., Qu, Panke, Faraone, Julia, Zheng, Yi-Min, Carlin, Claire, Bednash, Joseph S., Zhou, Tongqing, Lozanski, Gerard, Mallampalli, Rama, Saif, Linda J., Oltz, Eugene M., Mohler, Peter, Xu, Kai, Gumina, Richard J., Liu, Shan-Lu
Publicado 2021

Distinct Neutralizing Antibody Escape of SARS-CoV-2 Omicron Subvariants BQ.1, BQ.1.1, BA.4.6, BF.7 and BA.2.75.2

por Qu, Panke, Evans, John P., Faraone, Julia, Zheng, Yi-Min, Carlin, Claire, Anghelina, Mirela, Stevens, Patrick, Fernandez, Soledad, Jones, Daniel, Lozanski, Gerard, Panchal, Ashish, Saif, Linda J., Oltz, Eugene M., Xu, Kai, Gumina, Richard J., Liu, Shan-Lu
Publicado 2022

Neutralization of SARS-CoV-2 Omicron sub-lineages BA.1, BA.1.1, and BA.2

por Evans, John P., Zeng, Cong, Qu, Panke, Faraone, Julia, Zheng, Yi-Min, Carlin, Claire, Bednash, Joseph S., Zhou, Tongqing, Lozanski, Gerard, Mallampalli, Rama, Saif, Linda J., Oltz, Eugene M., Mohler, Peter J., Xu, Kai, Gumina, Richard J., Liu, Shan-Lu
Publicado 2022